M. Falqués

835 total citations
12 papers, 595 citations indexed

About

M. Falqués is a scholar working on Dermatology, Physiology and Surgery. According to data from OpenAlex, M. Falqués has authored 12 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Dermatology, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in M. Falqués's work include Gastrointestinal motility and disorders (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Dermatology and Skin Diseases (3 papers). M. Falqués is often cited by papers focused on Gastrointestinal motility and disorders (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Dermatology and Skin Diseases (3 papers). M. Falqués collaborates with scholars based in Spain, United States and Germany. M. Falqués's co-authors include J Fortea, S. Díaz-Insa, Peter J. Goadsby, G Zanchin, Hartmut Göbel, Ignasi Pau‐Charles, Nathalie Ivanoff, Nina De Klippel, G Géraud and Diamant Thaçi and has published in prestigious journals such as Gut, British Journal of Dermatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

M. Falqués

12 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Falqués Spain 9 194 179 173 170 148 12 595
Margie O’Leary United States 10 57 0.3× 78 0.4× 16 0.1× 43 0.3× 157 1.1× 18 577
Hang Zhang China 13 69 0.4× 25 0.1× 38 0.2× 8 0.0× 63 0.4× 63 517
M. Zeuner Germany 12 43 0.2× 12 0.1× 75 0.4× 48 0.3× 165 1.1× 19 601
Vinay Kalsi United Kingdom 14 88 0.5× 77 0.4× 5 0.0× 39 0.2× 88 0.6× 26 944
Mahir Uğur Türkiye 16 76 0.4× 70 0.4× 137 0.8× 38 0.2× 68 0.5× 37 688
M. Helmii Egypt 6 54 0.3× 32 0.2× 74 0.4× 68 0.4× 145 1.0× 17 311
Rania M. Gamal Egypt 12 56 0.3× 23 0.1× 61 0.4× 12 0.1× 84 0.6× 39 336
Akın Erdal Türkiye 13 54 0.3× 66 0.4× 124 0.7× 30 0.2× 85 0.6× 30 475
Rodolfo Molina United States 6 292 1.5× 44 0.2× 52 0.3× 16 0.1× 141 1.0× 9 425
Hyder Ridha United Kingdom 10 56 0.3× 15 0.1× 9 0.1× 34 0.2× 32 0.2× 21 497

Countries citing papers authored by M. Falqués

Since Specialization
Citations

This map shows the geographic impact of M. Falqués's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Falqués with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Falqués more than expected).

Fields of papers citing papers by M. Falqués

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Falqués. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Falqués. The network helps show where M. Falqués may publish in the future.

Co-authorship network of co-authors of M. Falqués

This figure shows the co-authorship network connecting the top 25 collaborators of M. Falqués. A scholar is included among the top collaborators of M. Falqués based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Falqués. M. Falqués is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Piraccini, Bianca Maria, Ulrike Blume‐Peytavi, M. Falqués, et al.. (2021). Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology. 36(2). 286–294. 75 indexed citations
2.
Thaçi, Diamant, Stefano Piaserico, Richard B. Warren, et al.. (2021). Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*. British Journal of Dermatology. 185(2). 323–334. 62 indexed citations
3.
Reich, Kristian, Richard B. Warren, Lars Iversen, et al.. (2019). Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks. British Journal of Dermatology. 182(3). 605–617. 107 indexed citations
4.
Kerkhof, P.C.M. van de, Robert Loewe, Ulrich Mrowietz, et al.. (2019). Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study. Journal of the European Academy of Dermatology and Venereology. 34(1). 119–126. 18 indexed citations
7.
8.
Quigley, Eamonn M.M., Jan Tack, William D. Chey, et al.. (2012). Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints. Alimentary Pharmacology & Therapeutics. 37(1). 49–61. 92 indexed citations
9.
Lembo, Anthony, J Fortea, M. Falqués, et al.. (2012). OC-082 26-Week efficacy and safety of once-daily oral linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a European perspective. Gut. 61(Suppl 2). A35.2–A36. 1 indexed citations
10.
Díaz-Insa, S., Peter J. Goadsby, G Zanchin, et al.. (2011). The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study. International Journal of Neuroscience. 121(12). 655–661. 18 indexed citations
11.
Magnussen, H, Henrik Watz, I. Zimmermann, et al.. (2009). Peak inspiratory flow through the Genuair® inhaler in patients with moderate or severe COPD. Respiratory Medicine. 103(12). 1832–1837. 58 indexed citations
12.
Goadsby, Peter J., G Zanchin, G Géraud, et al.. (2008). Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan. Cephalalgia. 28(4). 383–391. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026